{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:38:08Z","timestamp":1757777888602},"reference-count":52,"publisher":"Elsevier BV","issue":"48","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.vaccine.2015.10.105","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T13:25:02Z","timestamp":1446643502000},"page":"6641-6649","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Intranasal immunisation with recombinant adenovirus vaccines protects against a lethal challenge with pneumonia virus of mice"],"prefix":"10.1016","volume":"33","author":[{"given":"Helen E.","family":"Maunder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geraldine","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith N.","family":"Leppard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Easton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.10.105_bib0265","series-title":"Encyclopedia of virology","first-page":"324","article-title":"Mononegavirales","author":"Easton","year":"2008"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0270","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0275","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJMoa0804877","article-title":"The burden of respiratory syncytial virus infection in young children","volume":"360","author":"Hall","year":"2009","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0280","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/163.4.693","article-title":"Immunity to and frequency of reinfection with respiratory syncytial virus","volume":"163","author":"Hall","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0285","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1099\/vir.0.81786-0","article-title":"Unravelling the complexities of respiratory syncytial virus RNA synthesis","volume":"87","author":"Cowton","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0290","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0295","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nm.1894","article-title":"Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease","volume":"15","author":"Delgado","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0300","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.20020781","article-title":"A role for immune complexes in enhanced respiratory syncytial virus disease","volume":"196","author":"Polack","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0305","doi-asserted-by":"crossref","first-page":"e1004757","DOI":"10.1371\/journal.ppat.1004757","article-title":"RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets","volume":"11","author":"Knudson","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0310","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/427813","article-title":"Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants","volume":"191","author":"Karron","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0315","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1128\/JVI.01709-09","article-title":"Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB\/c mice, with no evidence of immunopathology","volume":"84","author":"Murawski","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0320","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.virusres.2009.06.012","article-title":"RSV fusion (F) protein DNA vaccine provides partial protection against viral infection","volume":"145","author":"Wu","year":"2009","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0325","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1128\/JVI.02372-07","article-title":"Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection","volume":"82","author":"Yu","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0330","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.bbrc.2008.10.002","article-title":"Protective effect of a RSV subunit vaccine candidate G1F\/M2 was enhanced by a HSP70-like protein in mice","volume":"377","author":"Zeng","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2004.09.001","article-title":"The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention","volume":"105","author":"Rosenberg","year":"2005","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0340","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1084\/jem.71.3.391","article-title":"A latent virus in normal mice mapable of producing pneumonia in its natural host","volume":"71","author":"Horsfall","year":"1940","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0345","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1099\/0022-1317-79-10-2411","article-title":"Pathogenesis of pneumovirus infections in mice: detection of pneumonia virus of mice and human respiratory syncytial virus mRNA in lungs of infected mice by in situ hybridization","volume":"79","author":"Cook","year":"1998","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0350","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.3390\/v4123494","article-title":"The pneumonia virus of mice (PVM) model of acute respiratory infection","volume":"4","author":"Dyer","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0355","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1016\/j.vaccine.2009.07.004","article-title":"Immunogenic properties of RSV-B1 fusion (F) protein gene-encoding recombinant adenoviruses","volume":"27","author":"Shao","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0360","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.4049\/jimmunol.175.10.6597","article-title":"Activation and inactivation of antiviral CD8 T cell responses during murine pneumovirus infection","volume":"175","author":"Claassen","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0365","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1002\/1521-4141(200209)32:9<2562::AID-IMMU2562>3.0.CO;2-4","article-title":"cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity","volume":"32","author":"Ostler","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0370","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4049\/jimmunol.166.2.1106","article-title":"Mucosal delivery of a respiratory syncytial virus CTL peptide with enterotoxin-based adjuvants elicits protective, immunopathogenic, and immunoregulatory antiviral CD8+ T cell responses","volume":"166","author":"Simmons","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0375","doi-asserted-by":"crossref","first-page":"6382","DOI":"10.1016\/j.vaccine.2012.08.027","article-title":"Pre-existing virus-specific CD8+ T-cells provide protection against pneumovirus-induced disease in mice","volume":"30","author":"van Helden","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0380","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1128\/JVI.69.11.6658-6664.1995","article-title":"Role of T-lymphocyte subsets in recovery from respiratory syncytial virus infection in calves","volume":"69","author":"Taylor","year":"1995","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0385","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.bbrc.2009.02.075","article-title":"Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB\/c mice","volume":"381","author":"Fu","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0390","doi-asserted-by":"crossref","first-page":"12601","DOI":"10.1128\/JVI.01036-09","article-title":"Protective efficacy and immunogenicity of an adenoviral vector vaccine encoding the codon-optimized F protein of respiratory syncytial virus","volume":"83","author":"Kohlmann","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0395","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1128\/JVI.79.10.6516-6522.2005","article-title":"Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates","volume":"79","author":"Santra","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0400","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.virol.2009.09.018","article-title":"Mucosal immunity induced by adenovirus-based H5N1 HPAI vaccine confers protection against a lethal H5N2 avian influenza virus challenge","volume":"395","author":"Park","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0405","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0410","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.4049\/jimmunol.150.12.5211","article-title":"Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins","volume":"150","author":"Alwan","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0415","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1128\/JVI.66.4.2102-2110.1992","article-title":"Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus","volume":"66","author":"Cherrie","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0420","doi-asserted-by":"crossref","first-page":"9949","DOI":"10.1128\/JVI.00339-13","article-title":"CD8+ T-cell epitope mapping for pneumonia virus of mice in H-2b mice","volume":"87","author":"Walsh","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0425","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.4049\/jimmunol.175.10.6597","article-title":"Activation and inactivation of antiviral CD8 T cell responses during murine pneumovirus infection","volume":"175","author":"Claassen","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0430","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1099\/0022-1317-78-12-3195","article-title":"Recombinant vaccinia viruses expressing the F G or N, but not the M2, protein of bovine respiratory syncytial virus (BRSV) induce resistance to BRSV challenge in the calf and protect against the development of pneumonic lesions","volume":"78","author":"Taylor","year":"1997","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0435","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1016\/j.vaccine.2008.06.100","article-title":"Vaccination of calves using the BRSV nucleocapsid protein in a DNA prime-protein boost strategy stimulates cell-mediated immunity and protects the lungs against BRSV replication and pathology","volume":"26","author":"Carine","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0440","doi-asserted-by":"crossref","first-page":"e1766","DOI":"10.1371\/journal.pone.0001766","article-title":"Sub-nucleocapsid nanoparticles: a nasal vaccine against respiratory syncytial F virus","volume":"3","author":"Roux","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0445","series-title":"Pathogenesis and persistence of pneumonia virus of mice","author":"Cook","year":"1996"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0450","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0092-8674(82)90310-5","article-title":"RNA is required for efficient translation of viral mRNAs at late times after infection","volume":"31","author":"Thimmappaya","year":"1982","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0455","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1099\/0022-1317-72-3-677","article-title":"Sequence of the major nucleocapsid protein gene of pneumonia virus of mice: sequence comparisons suggest structural homology between nucleocapsid proteins of pneumoviruses, paramyxoviruses, rhabdoviruses and filoviruses","volume":"72","author":"Barr","year":"1991","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0460","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0168-1702(96)01430-X","article-title":"Nucleotide sequence of the genes encoding the matrix and small hydrophobic proteins of pneumonia virus of mice","volume":"48","author":"Easton","year":"1997","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0465","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1016\/j.vaccine.2011.01.102","article-title":"A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo","volume":"29","author":"Easton","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0470","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.virol.2007.06.020","article-title":"Diminished inflammatory responses to natural pneumovirus infection among older mice","volume":"368","author":"Bonville","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0475","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors","volume":"10","author":"Tatsis","year":"2004","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0480","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1743-422X-10-183","article-title":"Intranasal immunization with a helper-dependent adenovirus vector expressing the codon-optimized fusion glycoprotein of human respiratory syncytial virus elicits protective immunity in BALB\/c mice","volume":"10","author":"Fu","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0485","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1016\/j.vaccine.2014.08.049","article-title":"Maternal immunization with chimpanzee adenovirus expressing RSV fusion protein protects against neonatal RSV pulmonary infection","volume":"32","author":"Sharma","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0490","doi-asserted-by":"crossref","first-page":"15018","DOI":"10.1038\/mtm.2015.18","article-title":"Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates","volume":"2","author":"Pierantoni","year":"2015","journal-title":"Mol Ther\u2014Methods Clin Dev"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0495","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1099\/vir.0.2008\/001891-0","article-title":"Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines","volume":"89","author":"See","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0500","doi-asserted-by":"crossref","first-page":"e10492","DOI":"10.1371\/journal.pone.0010492","article-title":"A Candidate H1N1 pandemic influenza vaccine elicits protective immunity in mice","volume":"5","author":"Steitz","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0505","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.vaccine.2009.10.145","article-title":"International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials","volume":"28","author":"Mast","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0510","doi-asserted-by":"crossref","first-page":"e3548","DOI":"10.1371\/journal.pone.0003548","article-title":"Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice","volume":"3","author":"Croyle","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0515","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature04721","article-title":"Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity","volume":"441","author":"Roberts","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.10.105_bib0520","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/JVI.02696-06","article-title":"Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D","volume":"81","author":"Abbink","year":"2007","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T18:52:56Z","timestamp":1692125576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15015613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":52,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0264410X15015613"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.105","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal immunisation with recombinant adenovirus vaccines protects against a lethal challenge with pneumonia virus of mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}